Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mmcgo002
    Member
    • Nov 2011
    • 10

    #1

    Interpreting an FPKM of 0

    I am still unclear of how to interpret an FPKM of 0 which you get for some genes in the cufflinks outputs.

    Does this mean that no reads have been mapped to this gene and therefore this gene can be considered as not a part of the transcriptome?

    Or does this mean that the gene is expressed but it is below a certain threshold, and if so should they be excluded from future analyses or comparisons.

    I am not doing a differential expression analysis--I'm just interested in what genes are or are not expressed, as I am doing a multi-species comparison between various mammalian species with genome assemblies.
  • Wallysb01
    Senior Member
    • Feb 2011
    • 286

    #2
    If you actually go look at a few genes with an FPKM of 0 on something like IGV, you'll see that sometime there are a few reads that align to it. Its just that when you're talking about 100M or more reads per sample, 1 or 2 reads is pretty insignificant. So, while you can't really say its not expressed with 100% certainty, you can say it was not detected. The other measure you can look at is if the low of the 95% confidence interval is >0. Then you can confidently claim something is expressed.

    Comment

    • cw11
      Member
      • Sep 2011
      • 12

      #3
      Side note - which version are you using? (I ask because there were some problems with 1.1.0 listing FPKMs as 0 when there were actually reads that mapped to those genes). I think they fixed this problem in 1.2.0.

      Comment

      • mmcgo002
        Member
        • Nov 2011
        • 10

        #4
        Thanks--that clears up that issue! I was using 1.1.0 but now I'm using 1.2.0. I think I'll rerun everything in 1.2.0, thanks for the heads-up!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        46 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        34 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        46 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        46 views
        0 reactions
        Last Post SEQadmin2  
        Working...